In melanoma study, CD31 and CD34 expression have been shown to be related to trans-differentiation of melanoma cells, thus implying that immunoreactivity for CD31 and CD34 is closely parallel with tumor progression and aggressive behavior of tumor cells16. This evidence concerns the gene PECAM1 and neoplasm.